Inogla Tablet

By Inogla

Rx

15 Tablet in a Strip

Composition icon

Composition

Teneligliptin(20mg)

Manufacturer - Wockhardt Ltd icon

Manufacturer - Wockhardt Ltd

Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India

Expires on or after icon

Expires on or after

December, 2025

About Inogla Tablet

Inogla Tablet is a medication used to manage type 2 diabetes mellitus. When paired with a balanced diet and regular physical activity, this tablet helps regulate blood sugar levels to prevent serious diabetes-related complications such as kidney damage and vision impairment. If your blood sugar remains uncontrolled with lifestyle changes or other medications, your doctor may consider prescribing Inogla Tablet either alone or in conjunction with other diabetes drugs. It can be ingested with or without food, and the dosage will be tailored to your specific needs and blood sugar levels. Adhering strictly to your doctor's instructions is crucial for maximum effectiveness.

Consistency is key when taking Inogla Tablet, as daily adherence at the same time each day is vital for optimal results. It is important not to discontinue the medication unless advised by your healthcare provider. By helping regulate blood sugar levels and mitigate diabetes-related risks, Inogla Tablet emphasizes the importance of maintaining the diet and exercise regimen recommended by your doctor. Managing diabetes is a comprehensive approach that highly values your lifestyle choices in controlling the condition.

While Inogla Tablet offers therapeutic benefits, there are potential side effects to be aware of, including hypoglycemia, constipation, dizziness, headache, and diarrhea. Recognizing symptoms of hypoglycemia, such as dizziness, sweating, and dry mouth, is crucial. In case of side effects persisting or causing concern, consulting with your doctor is advisable. Before initiating Inogla Tablet, patients with a history of kidney disease, heart issues, or pancreatic disorders should inform their healthcare providers. Pregnant or breastfeeding individuals should also seek medical advice. The risk of drug interactions underscores the importance of informing your doctor about all medications in use. Alcohol consumption should be limited due to the potential of triggering low blood sugar levels, requiring periodic medical evaluations to ensure the medication's efficacy.


Benefits

Inogla Tablet, containing Teneligliptin, is a medication classified as a DPP-4 inhibitor and is beneficial in the treatment of Type 2 diabetes mellitus. By stimulating the production of insulin in the body after meals and regulating the release of glucose into the bloodstream, Inogla Tablet effectively lowers blood glucose levels. This is crucial in managing diabetes and reducing the risk of severe complications such as kidney damage, vision impairment, and limb amputation associated with uncontrolled diabetes. Additionally, maintaining proper blood sugar levels through the use of Inogla Tablet can lower the chances of developing heart disease and stroke.


The mechanism of action of Inogla Tablet involves blocking the enzyme DPP-4, which is responsible for breaking down the hormone 'Incretin'. By preserving Incretin, the medication ensures that insulin is produced only as needed and prevents the liver from releasing excessive glucose into the blood. It is essential to note that Inogla Tablet is not suitable for individuals with type 1 diabetes or those experiencing diabetic ketoacidosis.


Overall, incorporating Inogla Tablet into a diabetes management regimen, including a balanced diet and regular exercise, is crucial for leading a healthy and normal life. Consistent use of this medication as prescribed by healthcare providers can significantly contribute to controlling blood sugar levels, preventing diabetic complications such as retinopathy, nephropathy, neuropathy, diabetic foot ulcers, and delayed wound healing. By prioritizing proper blood glucose regulation with the help of Inogla Tablet, individuals can enhance their quality of life and reduce the risks associated with unmanaged diabetes.


How to use the Inogla Tablet

To properly use Inogla Tablet, it is important to follow the directions provided by your doctor. Take the medicine in the exact dose and duration as prescribed. Swallow the tablet whole with a glass of water, without chewing, crushing, or breaking it. While you can take Inogla Tablet with or without food, it is recommended to take it at the same time each day for better effectiveness. If you experience stomach upset, it is advised to take the tablet with a meal to minimize any discomfort, following the guidance of your doctor. By following these instructions, you can ensure that you are using Inogla Tablet correctly and maximizing its potential benefits for your health.


Uses of Inogla Tablet

The Inogla Tablet is mainly used in the treatment of Type 2 diabetes mellitus. This medication is specifically designed to help manage and control blood sugar levels in individuals with this type of diabetes. By regulating blood sugar, the Inogla Tablet aids in reducing the symptoms and complications associated with Type 2 diabetes mellitus. This makes it a crucial part of the overall treatment plan for individuals living with this condition.


What conditions Inogla Tablet treats?

Inogla Tablet is commonly used for managing Type 2 Diabetes. This condition arises when the body cannot produce enough insulin or when the insulin produced is not effectively used. This leads to high blood sugar levels. Symptoms of Type 2 diabetes include increased thirst, frequent urination, slow wound healing, increased hunger, fatigue, and blurred vision. Complications that may arise from untreated Type 2 diabetes include nerve problems, kidney problems, eye damage, limb amputation, sexual dysfunction, and an increased risk of heart attack or stroke.


Should you consult a doctor?

If you experience symptoms of hypoglycemia, such as lightheadedness, sweating, dizziness, fainting, or dry mouth, it is important to seek medical help immediately. These are signs of low blood sugar levels that need prompt attention. Additionally, if you have persistent side effects like constipation, dizziness, headache, or diarrhea that do not go away or concern you, consult your doctor. It's crucial to inform your doctor if you have a history of kidney disease, heart disease, or pancreas problems before taking Inogla Tablet. Pregnant or breastfeeding women should also seek advice from their healthcare provider prior to starting this medication. Moreover, if you notice any unusual changes in your body temperature or have any other health concerns while taking Inogla Tablet, do not hesitate to reach out to your doctor. Regular monitoring through kidney function and blood glucose level tests is essential to ensure the medicine is working effectively. Remember to limit alcohol intake to reduce the risk of low blood sugar levels. Your doctor is your best source of guidance and support in managing your diabetes effectively.


Side effects of Inogla Tablet

Inogla Tablet may cause certain side effects, although most of them are generally mild and should go away as your body gets used to the medication. However, if any of these side effects persist or concern you, it's important to talk to your doctor. Some common side effects of Inogla Tablet include hypoglycemia (low blood glucose level), constipation, dizziness, headache, diarrhea, and increased body temperature. In addition, other possible side effects may include headaches, low blood glucose levels, upper respiratory tract infections, and nasopharyngitis which is an infection of the nose and throat often associated with the common cold. If you experience any of these side effects, consult your healthcare provider for guidance.


Safety advice

scroll

liver

When it comes to the safety of Inogla Tablet in relation to liver issues, it is important to note that this medication is considered safe for use in patients with liver disease. It is not usually necessary to adjust the dosage of Inogla Tablet specifically for liver issues. However, it is crucial to highlight that there is no clear clinical evidence supporting its use in patients with severe kidney impairment. Therefore, if you have a history or evidence of any liver-related diseases, it is highly advisable to consult your doctor before starting to take Inogla Tablet to ensure its suitability for your condition.

scroll

kidney

Inogla Tablet can be used safely in patients with kidney disease without needing a dose adjustment. However, if you have a history of kidney-related issues, it is advised to consult your doctor before taking this medication.

scroll

alcohol

It is unsafe to drink alcohol while taking Inogla Tablet. It is recommended to avoid alcohol when using this medication.

scroll

driving

When your blood sugar is too low or too high, it might affect your ability to drive. If you have symptoms, avoid driving. Also, refrain from driving if you feel dizzy.

scroll

pregnancy

Inogla Tablet is not recommended during pregnancy as limited studies have shown potential harm to the developing baby. Your doctor will evaluate the benefits and risks before prescribing this medication. Please consult your doctor before taking Inogla Tablet during pregnancy.

scroll

breastfeeding

Inogla Tablet may not be safe while breastfeeding. Limited data indicates possible transfer to breastmilk, which could harm the baby. Consult your doctor before using Inogla Tablet.


Consumption warning before consuming Inogla Tablet

Before consuming Inogla Tablet, it is important to note certain precautions. Do not take Inogla Tablet if you have an allergy to it or any of its components. If you are pregnant or breastfeeding, consult your doctor prior to using Inogla Tablet. It is not recommended for use in children since its safety and effectiveness in this group are not established. Long-term use of Inogla Tablet can lead to acute pancreatitis, and combining it with other anti-diabetic medications or insulin may increase the risk of hypoglycemia. If such combination is necessary, your doctor may adjust the dosage. Some individuals may experience severe allergic reactions such as anaphylaxis, skin swelling, or skin conditions while taking Inogla Tablet. Individuals with type 1 diabetes or diabetic ketoacidosis should avoid using Inogla Tablet.


What if you forgot to take Inogla Tablet?

If you forget to take a dose of Inogla Tablet, try to take it as soon as you remember. But, if it's nearly time for your next scheduled dose, it's better to skip the missed dose and continue with your normal dosing routine. Avoid taking a double dose to make up for the missed one. It is important to follow the prescribed dosing schedule for Inogla Tablet to ensure its effectiveness.


Related lab tests

When starting a new medication like Inogla Tablet, it is important to monitor certain lab tests to ensure that the treatment is effective and safe for you. The related lab tests for Inogla Tablet include:


1. Glucose - Fasting Blood Test: This test measures the amount of glucose in your blood after you have not eaten for at least 8 hours. It helps to evaluate your fasting blood sugar levels and detect any potential issues with your body's ability to regulate blood sugar.


2. Glucose - Postprandial Blood Test: This test measures the amount of glucose in your blood 2 hours after a meal. It helps to assess how your body processes glucose after eating and can provide important insights into your insulin sensitivity and overall blood sugar control.


3. Glycosylated Hemoglobin (HbA1c) Test: This test measures the average blood sugar levels over the past 2-3 months by assessing the amount of glucose that is bound to hemoglobin in red blood cells. It is a crucial indicator of long-term blood sugar control and can help in managing diabetes effectively.


By regularly monitoring these related lab tests as advised by your healthcare provider, you can track your response to Inogla Tablet treatment and make necessary adjustments to ensure optimal health outcomes.


Additional Information

Habit FormingNo
Chemical ClassAlpha amino acid amides
Therapeutic ClassANTI DIABETIC
Action ClassDPP-4 inhibitors

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

186.14

Inclusive of all taxes

Content verified by

chevron-right

Dr. Archana Prabhakar

MBBS, M.Med (Family Medicine)

Last update on 18-Nov-2024